3,4-dihydroxybenzohydroxamic acid has been researched along with Benign Neoplasms, Brain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Figul, M | 1 |
| Söling, A | 1 |
| Dong, HJ | 1 |
| Chou, TC | 1 |
| Rainov, NG | 1 |
| Horvath, Z | 2 |
| Höchtl, T | 1 |
| Bauer, W | 2 |
| Fritzer-Szekeres, M | 2 |
| Elford, HL | 1 |
| Szekeres, T | 2 |
| Tihan, T | 2 |
| Hoechtl, T | 1 |
| Saiko, P | 1 |
3 other studies available for 3,4-dihydroxybenzohydroxamic acid and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells.
Topics: Antineoplastic Agents, Alkylating; Benzamidines; Brain Neoplasms; Dacarbazine; Drug Synergism; Enzym | 2003 |
Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cere | 2004 |
Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
Topics: Animals; Anti-Infective Agents, Local; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Ant | 2004 |